Modification  ||| S:0 E:13 ||| NNP
and  ||| S:13 E:17 ||| CC
implementation  ||| S:17 E:32 ||| NN
of  ||| S:32 E:35 ||| IN
NCCN  ||| S:35 E:40 ||| NNP
guidelines  ||| S:40 E:51 ||| NNS
on  ||| S:51 E:54 ||| IN
prostate  ||| S:54 E:63 ||| JJ
cancer  ||| S:63 E:70 ||| NN
in  ||| S:70 E:73 ||| IN
the  ||| S:73 E:77 ||| DT
Middle  ||| S:77 E:84 ||| NNP
East  ||| S:84 E:89 ||| NNP
and  ||| S:89 E:93 ||| CC
North  ||| S:93 E:99 ||| NNP
Africa  ||| S:99 E:106 ||| NNP
region  ||| S:106 E:113 ||| NN
A  ||| S:113 E:115 ||| DT
prostate  ||| S:115 E:124 ||| JJ
cancer  ||| S:124 E:131 ||| NN
committee  ||| S:131 E:141 ||| NN
was  ||| S:141 E:145 ||| VBD
established  ||| S:145 E:157 ||| VBN
to  ||| S:157 E:160 ||| TO
modify  ||| S:160 E:167 ||| VB
the  ||| S:167 E:171 ||| DT
NCCN  ||| S:171 E:176 ||| NNP
Clinical  ||| S:176 E:185 ||| NNP
Practice  ||| S:185 E:194 ||| NNP
Guidelines  ||| S:194 E:205 ||| NNP
in  ||| S:205 E:208 ||| IN
Oncology  ||| S:208 E:217 ||| NNP
( ||| S:217 E:218 ||| -LRB-
NCCN  ||| S:218 E:223 ||| NNP
Guidelines ||| S:223 E:233 ||| NNP
)  ||| S:233 E:235 ||| -RRB-
on  ||| S:235 E:238 ||| IN
Prostate  ||| S:238 E:247 ||| NNP
Cancer  ||| S:247 E:254 ||| NNP
for  ||| S:254 E:258 ||| IN
adaptation  ||| S:258 E:269 ||| NN
and  ||| S:269 E:273 ||| CC
implementation  ||| S:273 E:288 ||| NN
in  ||| S:288 E:291 ||| IN
the  ||| S:291 E:295 ||| DT
Middle  ||| S:295 E:302 ||| NNP
East  ||| S:302 E:307 ||| NNP
and  ||| S:307 E:311 ||| CC
North  ||| S:311 E:317 ||| NNP
Africa  ||| S:317 E:324 ||| NNP
( ||| S:324 E:325 ||| -LRB-
MENA ||| S:325 E:329 ||| NNP
)  ||| S:329 E:331 ||| -RRB-
region ||| S:331 E:337 ||| NN
.  ||| S:337 E:339 ||| .
The  ||| S:339 E:343 ||| DT
objective  ||| S:343 E:353 ||| NN
was  ||| S:353 E:357 ||| VBD
to  ||| S:357 E:360 ||| TO
enhance  ||| S:360 E:368 ||| VB
the  ||| S:368 E:372 ||| DT
multidisciplinary  ||| S:372 E:390 ||| JJ
approach  ||| S:390 E:399 ||| NN
to  ||| S:399 E:402 ||| TO
the  ||| S:402 E:406 ||| DT
treatment  ||| S:406 E:416 ||| NN
of  ||| S:416 E:419 ||| IN
prostate  ||| S:419 E:428 ||| JJ
cancer ||| S:428 E:434 ||| NN
.  ||| S:434 E:436 ||| .
The  ||| S:436 E:440 ||| DT
committee ||| S:440 E:449 ||| NN
,  ||| S:449 E:451 ||| ,
comprising  ||| S:451 E:462 ||| VBG
regional  ||| S:462 E:471 ||| JJ
experts  ||| S:471 E:479 ||| NNS
in  ||| S:479 E:482 ||| IN
the  ||| S:482 E:486 ||| DT
fields  ||| S:486 E:493 ||| NNS
of  ||| S:493 E:496 ||| IN
urologic ||| S:496 E:504 ||| NN
,  ||| S:504 E:506 ||| ,
medical ||| S:506 E:513 ||| JJ
,  ||| S:513 E:515 ||| ,
and  ||| S:515 E:519 ||| CC
radiation  ||| S:519 E:529 ||| NN
oncology ||| S:529 E:537 ||| NN
,  ||| S:537 E:539 ||| ,
reviewed  ||| S:539 E:548 ||| VBN
the  ||| S:548 E:552 ||| DT
2009  ||| S:552 E:557 ||| CD
version  ||| S:557 E:565 ||| NN
of  ||| S:565 E:568 ||| IN
the  ||| S:568 E:572 ||| DT
NCCN  ||| S:572 E:577 ||| NNP
Guidelines  ||| S:577 E:588 ||| NNP
on  ||| S:588 E:591 ||| IN
Prostate  ||| S:591 E:600 ||| NNP
Cancer  ||| S:600 E:607 ||| NNP
and  ||| S:607 E:611 ||| CC
suggested  ||| S:611 E:621 ||| VBD
modifications  ||| S:621 E:635 ||| NNS
based  ||| S:635 E:641 ||| VBN
on  ||| S:641 E:644 ||| IN
the  ||| S:644 E:648 ||| DT
unique  ||| S:648 E:655 ||| JJ
needs  ||| S:655 E:661 ||| NNS
of  ||| S:661 E:664 ||| IN
the  ||| S:664 E:668 ||| DT
regions  ||| S:668 E:676 ||| NNS
determined  ||| S:676 E:687 ||| VBN
through  ||| S:687 E:695 ||| IN
published  ||| S:695 E:705 ||| JJ
evidence  ||| S:705 E:714 ||| NN
and  ||| S:714 E:718 ||| CC
local  ||| S:718 E:724 ||| JJ
expertise ||| S:724 E:733 ||| NN
.  ||| S:733 E:735 ||| .
The  ||| S:735 E:739 ||| DT
committee  ||| S:739 E:749 ||| NN
identified  ||| S:749 E:760 ||| VBN
several  ||| S:760 E:768 ||| JJ
areas  ||| S:768 E:774 ||| NNS
in  ||| S:774 E:777 ||| IN
the  ||| S:777 E:781 ||| DT
NCCN  ||| S:781 E:786 ||| NNP
Guidelines  ||| S:786 E:797 ||| NNP
that  ||| S:797 E:802 ||| IN
they  ||| S:802 E:807 ||| PRP
believed  ||| S:807 E:816 ||| VBD
required  ||| S:816 E:825 ||| VBN
modification ||| S:825 E:837 ||| NN
,  ||| S:837 E:839 ||| ,
which  ||| S:839 E:845 ||| WDT
are  ||| S:845 E:849 ||| VBP
presented  ||| S:849 E:859 ||| VBN
in  ||| S:859 E:862 ||| IN
this  ||| S:862 E:867 ||| DT
article ||| S:867 E:874 ||| NN
.  ||| S:874 E:876 ||| .
The  ||| S:876 E:880 ||| DT
treatment  ||| S:880 E:890 ||| NN
of  ||| S:890 E:893 ||| IN
prostate  ||| S:893 E:902 ||| JJ
cancer  ||| S:902 E:909 ||| NN
in  ||| S:909 E:912 ||| IN
the  ||| S:912 E:916 ||| DT
MENA  ||| S:916 E:921 ||| NNP
region  ||| S:921 E:928 ||| NN
has  ||| S:928 E:932 ||| VBZ
numerous  ||| S:932 E:941 ||| JJ
challenges ||| S:941 E:951 ||| NNS
.  ||| S:951 E:953 ||| .
The  ||| S:953 E:957 ||| DT
hope  ||| S:957 E:962 ||| NN
is  ||| S:962 E:965 ||| VBZ
that  ||| S:965 E:970 ||| IN
this  ||| S:970 E:975 ||| DT
effort  ||| S:975 E:982 ||| NN
to  ||| S:982 E:985 ||| TO
modify  ||| S:985 E:992 ||| VB
the  ||| S:992 E:996 ||| DT
NCCN  ||| S:996 E:1001 ||| NNP
Guidelines  ||| S:1001 E:1012 ||| NNP
on  ||| S:1012 E:1015 ||| IN
Prostate  ||| S:1015 E:1024 ||| NNP
Cancer  ||| S:1024 E:1031 ||| NNP
for  ||| S:1031 E:1035 ||| IN
practical  ||| S:1035 E:1045 ||| JJ
use  ||| S:1045 E:1049 ||| NN
in  ||| S:1049 E:1052 ||| IN
the  ||| S:1052 E:1056 ||| DT
MENA  ||| S:1056 E:1061 ||| NNP
region  ||| S:1061 E:1068 ||| NN
will  ||| S:1068 E:1073 ||| MD
improve  ||| S:1073 E:1081 ||| VB
regional  ||| S:1081 E:1090 ||| JJ
awareness  ||| S:1090 E:1100 ||| NN
and  ||| S:1100 E:1104 ||| CC
patient  ||| S:1104 E:1112 ||| JJ
care ||| S:1112 E:1116 ||| NN
.  ||| S:1116 E:1118 ||| .
